Dermatology | Oncology | Pathology Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosis. January 3, 2024
Oncology | Pathology | Urology Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. July 1, 2023
Medical Imaging | Oncology | Radiation Oncology Prognosis Forecast of Re-irradiation for Recurrent Nasopharyngeal Carcinoma based on Deep Learning Multi-modal Information Fusion. June 29, 2023
Oncology | Pathology | Urology Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology. June 26, 2023
Oncology | Radiology | Surgery Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma. May 16, 2023
Oncology | Pathology Predicting the recurrence and overall survival of patients with glioma based on histopathological images using deep learning. April 17, 2023
Gynecology | Oncology A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches. November 15, 2022
Oncology | Pathology | Precision Medicine ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data. October 15, 2022
Endocrinology | Neurosurgery | Radiology Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features. May 6, 2022
Oncology | Radiology Evaluation of the Risk of Recurrence in Patients with Local Advanced Rectal Tumours by Different Radiomic Analysis Approaches. December 8, 2021
Oncology | Radiology Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach. August 12, 2021
Biostatistics | Oncology | Urology Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. June 7, 2021